Skip to main content
. 2016 Oct 4;23(6):293–299. doi: 10.1016/j.jpge.2016.06.003

Table 1.

Demographics and clinicopathological parameters of all patients who underwent SEMS insertion.

Bridge to surgery group (n = 27) Palliation group (n = 9) p Total (n = 36)
Sex ratio (F:M) 17:10 3:6 0.146 20:16
Age (years ± SD) 68.2 ± 10.2 77.9 ± 10.1 0.018 70.6 ± 10.9
ASA (n (%)) 0.254
 I 1 (4) 0 1 (3)
 II 18 (66) 4 (44) 22 (61)
 III 7 (26) 4 (44) 11 (31)
 IV 1 (4) 1 (11) 2 (6)
Tumor length (cm ± SD) 3.17 ± 0.71 3.3 ± 0.58 3.21 ± 0.66



Tumor location (n (%)) 0.293
 Rectum-sigmoid 4 (15) 4 (44) 8 (22)
 Sigmoid 14 (52) 3 (33) 17 (47)
 Descending colon 8 (30) 1 (11) 9 (25)
 Splenic flexure 1 (4) 1 (11) 2 (6)



Pathological stage (n (%)) 0.011
 I 0 0 0
 II 10 (37) 1 (11) 11 (31)
 III 11 (41) 1 (11) 12 (33)
 IV 6 (22) 7 (78) 13 (36)



Tumor differentiation (n (%)) 0.701
 Well 4 (15) 1 (11) 5 (14)
 Moderate 22 (81) 6 (67) 28 (78)
 Poor 1 (4) 2 (22) 3 (8)
Technical success (n (%)) 26 (96) 8 (89) 0.443 34 (94)
Clinical success (n (%)) 26 (96) 8 (89) 0.443 34 (94)



Complications (n (%)) 0.121
 Migration 2 (7) 0 2 (6)
 Perforation (overt and silent) 6 (22) 3 (33) 9 (25)
Mortality (n (%)) 5 (19) 5 (56) 0.120 10 (28)
Follow-up (months ± SD) 14.7 ± 10.9 3 ± 1.7 0.004 11.8 ± 10.7